A randomised controlled pilot study comparing Mepitel(®) and SurfaSoft(®) on paediatric donor sites treated with...

Area of Science:

• Dermatology
• Wound Healing
• Regenerative Medicine

Background:

• Paediatric donor sites require dressings that promote healing and minimize patient discomfort.
• Epithelial cell suspension (ReCell®) is a treatment for burns, necessitating optimal wound coverage.
• Comparing dressing types is crucial for improving patient outcomes in paediatric burn care.

Purpose of the Study:

• To compare the efficacy of Mepitel® (silicone net dressing) versus SurfaSoft® (polyamide woven dressing) on paediatric donor sites treated with ReCell®.
• To evaluate the impact of these dressings on epithelialisation rate, epidermal maturation, pain, and ease of dressing removal.
• To provide preliminary data for future research on advanced wound care for paediatric burns.

Main Methods:

• A randomized controlled pilot study involving 15 paediatric patients (1-15 years) with burns.
• Patients were assigned to receive either Mepitel® (n=8) or SurfaSoft® (n=7) dressing over ReCell®-treated donor sites.
• Data on epithelialisation, epidermal maturation, pain, and dressing removal force were collected every two days until wound healing.

Main Results:

• No significant difference in the rate of epidermal maturation between Mepitel® and SurfaSoft® groups.
• The Mepitel® group experienced significantly less pain and required less force for dressing removal compared to the SurfaSoft® group.
• The rate of epithelialisation was found to be an unreliable measure in this study.

Conclusions:

• Mepitel® dressings may offer advantages over SurfaSoft® for ReCell®-treated paediatric donor sites, primarily due to reduced pain and easier removal.
• The pliable, self-adhesive, and atraumatic properties of Mepitel® appear beneficial for wound healing and patient comfort.
• This pilot study supports further investigation into Mepitel® for optimizing paediatric burn wound management.